Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001129928-23-000020
Filing Date
2023-04-12
Accepted
2023-04-12 09:25:25
Documents
2
Period of Report
2023-04-12

Document Format Files

Seq Description Document Type Size
1 6-K form6k2023canaccordhorizon.htm 6-K 18317
2 EX-99.1 canaccordhorizonsconfpr.htm EX-99.1 9218
  Complete submission text file 0001129928-23-000020.txt   28481
Mailing Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5
Business Address 804, 322 - 11 AVENUE SW CALGARY A0 T2R 0C5 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38512 | Film No.: 23814795
SIC: 2834 Pharmaceutical Preparations